Kupffer Cells in the Liver
Open accessThe DOI matches its Crossref record; 158 of the 158 references it cites were found in a registry or an index.
Abstract
Kupffer cells are a critical component of the mononuclear phagocytic system and are central to both the hepatic and systemic response to pathogens. Kupffer cells are reemerging as critical mediators of both liver injury and repair. Kupffer cells exhibit a tremendous plasticity; depending on the local metabolic and immune environment, then can express a range of polarized phenotypes, from the proinflammatory M1 phenotype to the alternative/M2 phenotype. Multiple M2 phenotypes can be distinguished, each involved in the resolution of inflammation and wound healing. Here, we have provided an update on recent research that has contributed to the developing delineation of the contribution of Kupffer cells to different types of liver injury, with an emphasis on alcoholic and nonalcoholic liver diseases. These recent advances in our understanding of Kupffer cell function and regulation will likely provide new insights into the potential for therapeutic manipulation of Kupffer cells to promote the resolution of inflammation and enhance wound healing in liver disease. © 2013 American Physiological Society.Compr Physiol 3:785‐797, 2013.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Both PAMPs and LPS activate Kupffer cells, which subsequently synthesize two key cytokines—IL-6[45] and tumour necrosis factor-alpha (TNF-α)[46].”
From Liver regeneration after partial hepatectomy: Triggers and mechanisms (2025) · cites this paper as [46]
In the citing paper
“Kupffer cells are not only sensitive to inflammatory signals but also to metabolic challenges such as dyslipidemia, which affects Kupffer cell activation in models of liver steatosis and steatohepatitis [300,301].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [300]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
Monocyte and macrophage heterogeneity
Gordon, S., & Taylor, P. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1733 · Cited by 5,190
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664
TLR4 links innate immunity and fatty acid-induced insulin resistance
Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690
Walport, M. J. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441406 · Cited by 2,927
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Vandanmagsar, B., Youm, Y.-H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E., Stephens, J. M., & Dixit, V. D. (2011) · Nature Medicine · doi:10.1038/nm.2279 · Cited by 2,655
Mechanisms of Hepatic Fibrogenesis
Friedman, S. L. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.003 · Cited by 2,634
Nod2 Is a General Sensor of Peptidoglycan through Muramyl Dipeptide (MDP) Detection
Girardin, S. E., Boneca, I. G., Viala, J., Chamaillard, M., Labigne, A., Thomas, G., Philpott, D. J., & Sansonetti, P. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200651200 · Cited by 2,408
Transcriptional regulation of macrophage polarization: enabling diversity with identity
Lawrence, T., & Natoli, G. (2011) · Nature Reviews Immunology · doi:10.1038/nri3088 · Cited by 2,284
Research works printed but not linked: 2
- Hillian AH, 2012, C1q in the classical pathway is required for high fat diet induced insulin resistance, Diabetes
- Younossi ZN, 1995, Clinics in Liver Disease
Cited by
Macrophages: Development and Tissue Specialization
Varol, C., Mildner, A., & Jung, S. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112220 · Cited by 962
“However, under disease conditions, they can shift to a pathologically activated state and then cause hepatocellular injury and damage (151, 152).”
BackgroundPeiseler, M., Schwabe, R., Hampe, J., Kubes, P., Heikenwälder, M., & Tacke, F. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.06.012 · Cited by 564
Innate Immunity and Inflammation in NAFLD/NASH
Arrese, M., Cabrera, D., Kalergis, A. M., & Feldstein, A. E. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4049-x · Cited by 492
Wnt/β-Catenin Signaling in Liver Development, Homeostasis, and Pathobiology
Russell, J. O., & Monga, S. P. (2018) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-044010 · Cited by 471
Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review
Oura, K., Morishita, A., Tani, J., & Masaki, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115801 · Cited by 426
Sakai, M., Troutman, T. D., Seidman, J. S., Ouyang, Z., Spann, N. J., Abe, Y., Ego, K. M., Bruni, C. M., Deng, Z., Schlachetzki, J. C. M., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.09.002 · Cited by 418
Autophagy in liver diseases: A review
Qian, H., Chao, X., Williams, J., Fulte, S., Li, T., Yang, L., & Ding, W.-X. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.100973 · Cited by 373
Yang, L., Chu, Z., Liu, M., Zou, Q., Li, J., Liu, Q., Wang, Y., Wang, T., Xiang, J., & Wang, B. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01453-1 · Cited by 352
Kumar, S., Duan, Q., Wu, R., Harris, E. N., & Su, Q. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113869 · Cited by 351
Xu, X., Poulsen, K. L., Wu, L., Liu, S., Miyata, T., Song, Q., Wei, Q., Zhao, C., Lin, C., & Yang, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01119-3 · Cited by 359
The Role of Macrophages in Staphylococcus aureus Infection
Pidwill, G. R., Gibson, J. F., Cole, J., Renshaw, S. A., & Foster, S. J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.620339 · Cited by 341
PPAR-γ signaling in nonalcoholic fatty liver disease: Pathogenesis and therapeutic targets
Chen, H., Tan, H., Wan, J., Zeng, Y., Wang, J., Wang, H., & Lu, X. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108391 · Cited by 311
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions
Lonardo, A., Nascimbeni, F., Targher, G., Bernardi, M., Bonino, F., Bugianesi, E., Casini, A., Gastaldelli, A., Marchesini, G., Marra, F., et al. (2017) · Digestive and Liver Disease · doi:10.1016/j.dld.2017.01.147 · Cited by 306
Luo, W., Xu, Q., Wang, Q., Wu, H., & Hua, J. (2017) · Scientific Reports · doi:10.1038/srep44612 · Cited by 282
Ibrahim, S. H., Hirsova, P., & Gores, G. J. (2018) · Gut · doi:10.1136/gutjnl-2017-315691 · Cited by 278
Kumar, M., Kulkarni, P., Liu, S., Chemuturi, N., & Shah, D. K. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114708 · Cited by 245
Targeting Oxidative Stress for the Treatment of Liver Fibrosis
Luangmonkong, T., Suriguga, S., Mutsaers, H. A. M., Groothuis, G. M. M., Olinga, P., & Boersema, M. (2018) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/112_2018_10 · Cited by 245
Non-alcoholic fatty liver and the gut microbiota
Bashiardes, S., Shapiro, H., Rozin, S., Shibolet, O., & Elinav, E. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.06.003 · Cited by 241
The role of Kupffer cells in hepatic diseases
Li, P., He, K., Li, J., Liu, Z., & Gong, J. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.02.018 · Cited by 233
Molecular Pathogenesis of NASH
Caligiuri, A., Gentilini, A., & Marra, F. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091575 · Cited by 209
Relevance of SIRT1-NF-κB Axis as Therapeutic Target to Ameliorate Inflammation in Liver Disease
de Gregorio, E., Colell, A., Morales, A., & Marí, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113858 · Cited by 197
Extracellular Matrix Remodeling in Chronic Liver Disease
Ortiz, C., Schierwagen, R., Schaefer, L., Klein, S., Trepat, X., & Trebicka, J. (2021) · Current Tissue Microenvironment Reports · doi:10.1007/s43152-021-00030-3 · Cited by 177
Function of CSF1 and IL34 in Macrophage Homeostasis, Inflammation, and Cancer
Lin, W., Xu, D., Austin, C. D., Caplazi, P., Senger, K., Sun, Y., Jeet, S., Young, J., Delarosa, D., Suto, E., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02019 · Cited by 190
Targeting of Hepatic Macrophages by Therapeutic Nanoparticles
Colino, C. I., Lanao, J. M., & Gutierrez-Millan, C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00218 · Cited by 184
In vivo Biodistribution and Clearance of Magnetic Iron Oxide Nanoparticles for Medical Applications
Nowak-Jary, J., & Machnicka, B. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s415063 · Cited by 166
Fernando, D. H., Forbes, J. M., Angus, P. W., & Herath, C. B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205037 · Cited by 184
Bacterial extracellular vesicles: an emerging avenue to tackle diseases
Xie, J., Haesebrouck, F., Van Hoecke, L., & Vandenbroucke, R. E. (2023) · Trends in Microbiology · doi:10.1016/j.tim.2023.05.010 · Cited by 165
Li, J., Chen, C., & Xia, T. (2022) · Advanced Materials · doi:10.1002/adma.202106456 · Cited by 162
Non-alcoholic Fatty Liver Disease: A Clinical Update
Pappachan, J. M., Babu, S. V., Krishnan, B., & Ravindran, N. (2017) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2017.00013 · Cited by 193
Hepatic Hippo signaling inhibits protumoural microenvironment to suppress hepatocellular carcinoma
Kim, W., Khan, S. K., Liu, Y., Xu, R., Park, O., He, Y., Cha, B., Gao, B., & Yang, Y. (2018) · Gut · doi:10.1136/gutjnl-2017-314061 · Cited by 160
Han, Y., Kim, H., Na, H., Nam, M.-W., Kim, J.-Y., Kim, J.-S., Koo, S., & Lee, M.-O. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.017 · Cited by 163
Mechanisms of liver disease in patients infected with HIV
Kaspar, M. B., & Sterling, R. K. (2017) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2017-000166 · Cited by 158
A Potent Branched-Tail Lipid Nanoparticle Enables Multiplexed mRNA Delivery and Gene Editing In Vivo
Hajj, K. A., Melamed, J. R., Chaudhary, N., Lamson, N. G., Ball, R. L., Yerneni, S. S., & Whitehead, K. A. (2020) · Nano Letters · doi:10.1021/acs.nanolett.0c00596 · Cited by 155
Ohara, M., Ohnishi, S., Hosono, H., Yamamoto, K., Yuyama, K., Nakamura, H., Fu, Q., Maehara, O., Suda, G., & Sakamoto, N. (2018) · Stem Cells International · doi:10.1155/2018/3212643 · Cited by 155
Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured?
Khanam, A., Saleeb, P. G., & Kottilil, S. (2021) · Cells · doi:10.3390/cells10051097 · Cited by 150
Macrophage Phenotype in Liver Injury and Repair
Sun, Y., Li, X., Meng, X., Huang, C., Zhang, L., & Li, J. (2016) · Scandinavian Journal of Immunology · doi:10.1111/sji.12468 · Cited by 143
A Cell-type-resolved Liver Proteome
Ding, C., Li, Y., Guo, F., Jiang, Y., Ying, W., Li, D., Yang, D. C., Xia, X., Liu, W., Zhao, Y., et al. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m116.060145 · Cited by 149
Oxidative Stress and Redox Signaling in the Pathophysiology of Liver Diseases
Mooli, R. G. R., Mukhi, D., & Ramakrishnan, S. K. (2022) · Comprehensive physiology · doi:10.1002/cphy.c200021 · Cited by 151
Zeng, T., Zhang, C., Xiao, M., Yang, R., & Xie, K. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00538 · Cited by 137
Wang, Y., Zhong, X., He, X., Hu, Z., Huang, H., Chen, J., Chen, K., Zhao, S., Wei, P., & Li, D. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02729-7 · Cited by 147
Beyer, D., Hoff, J., Sommerfeld, O., Zipprich, A., Gaßler, N., & Press, A. T. (2022) · Molecular Medicine · doi:10.1186/s10020-022-00510-8 · Cited by 140
Berthier, A., Johanns, M., Zummo, F. P., Lefebvre, P., & Staels, B. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166097 · Cited by 125
“KCs dynamically contribute to inflammation and wound healing responses by acquiring pro-or anti-inflammatory phenotypes [42].”
BackgroundTorre, S. D. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.572490 · Cited by 143
Pathogenesis of Kupffer Cells in Cholestatic Liver Injury
Sato, K., Hall, C. M., Glaser, S. S., Francis, H., Meng, F., & Alpini, G. D. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.06.003 · Cited by 126
Babuta, M., Morel, C., Ribeiro, M. D. C., Calenda, C. D., Ortega‐Ribera, M., Nagesh, P. T., Copeland, C., Zhuang, Y., Wang, Y., Cho, Y., et al. (2024) · Gut · doi:10.1136/gutjnl-2023-331447 · Cited by 127
How Inflammation Impinges on NAFLD: A Role for Kupffer Cells
Duarte, N., Coelho, I. C., Patarrão, R. S., Almeida, J. I., Penha-Gonçalves, C., & Macedo, M. P. (2015) · BioMed Research International · doi:10.1155/2015/984578 · Cited by 120
“In vitro assays demonstrated that these fat-ladenKCsweremore responsive to LPS induced activation when compared to KCs from lean mice [68].”
Potential Biosafety of Mxenes: Stability, Biodegradability, Toxicity and Biocompatibility
Dmytriv, T. R., & Lushchak, V. I. (2024) · The Chemical Record · doi:10.1002/tcr.202300338 · Cited by 125
Cell senescence in liver diseases: pathological mechanism and theranostic opportunity
Sanfeliu-Redondo, D., Gibert-Ramos, A., & Gracia-Sancho, J. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00913-4 · Cited by 117
Functional Immune Anatomy of the Liver—As an Allograft
Demetris, A. J., Bellamy, C. O. C., Gandhi, C. R., Prost, S., Nakanuma, Y., & Stolz, D. B. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13749 · Cited by 121
Jang, W. Y., Hwang, J. Y., & Cho, J. Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076119 · Cited by 121
Porphyromonas gingivalis Infection Induces Amyloid-β Accumulation in Monocytes/Macrophages
Nie, R., Wu, Z., Ni, J., Zeng, F., Yu, W., Zhang, Y., Kadowaki, T., Kashiwazaki, H., Teeling, J. L., & Zhou, Y. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190298 · Cited by 126
CD4+ T cell activation and inflammation in NASH-related fibrosis
Zhou, Y., Zhang, H., Yao, Y., Zhang, X., Guan, Y., & Zheng, F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.967410 · Cited by 125
Nowak, A. J., & Relja, B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249407 · Cited by 119
Bartkowiak, T., Jaiswal, A. R., Ager, C. R., Chin, R. L., Chen, C.-H., Budhani, P., Ai, M., Reilley, M. J., Sebastian, M. M., Hong, D. S., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1847 · Cited by 115
Zhao, H. Y., Liu, S., He, J., Pan, C. C., Li, H., Zhou, Z. Y., Ding, Y., Huo, D., & Hu, Y. M. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.02.019 · Cited by 108
Obesity: An Immunometabolic Perspective
Ray, I., Mahata, S. K., & De, R. K. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00157 · Cited by 118
Zhao, P., & Saltiel, A. R. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.011356 · Cited by 109
Inflammatory processes in the liver: divergent roles in homeostasis and pathology
Ahmed, O., Robinson, M. W., & O’Farrelly, C. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00639-2 · Cited by 111
Baze, A., Parmentier, C., Hendriks, D. F. G., Hurrell, T., Heyd, B., Bachellier, P., Schuster, C., Ingelman‐Sundberg, M., & Richert, L. (2018) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2018.0134 · Cited by 103
Wu, H., Ni, X., Xu, Q., Wang, Q., Li, X., & Hua, J. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15025 · Cited by 105
Gao, J., Wei, B., Liu, M., Hirsova, P., Sehrawat, T. S., Cao, S., Hu, X., Xue, F., Yaqoob, U., Kang, N., et al. (2021) · Hepatology · doi:10.1002/hep.31617 · Cited by 100
Kang, J., & Lee, S. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.06.002 · Cited by 104
Rose, K. A., Holman, N. S., Green, A. M., Andersen, M. E., & LeCluyse, E. L. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/s0022-3549(15)00192-6 · Cited by 99
Burhans, W. S., Rossiter-Burhans, C. A., & Baumgard, L. H. (2022) · Journal of Dairy Science · doi:10.3168/jds.2021-21080 · Cited by 95
Brocker, C. N., Yue, J., Kim, D., Qu, A., Bonzo, J. A., & Gonzalez, F. J. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00205.2016 · Cited by 93
Sun, K., Xu, L., Jing, Y., Han, Z., Chen, X., Cai, C., Zhao, P., Zhao, X., Yang, L., & Wei, L. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.12.004 · Cited by 95
Beyond the X Factor: Relevance of Sex Hormones in NAFLD Pathophysiology
Torre, S. D. (2021) · Cells · doi:10.3390/cells10092502 · Cited by 101
Liver innate immune cells and insulin resistance: the multiple facets of Kupffer cells
Jager, J., Aparicio‐Vergara, M., & Aouadi, M. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12483 · Cited by 90
Barr, R. G., Huang, P., Luo, Y., Xie, X., Zheng, R., Yan, K., Jing, X., Luo, Y., Xu, H., Fei, X., et al. (2020) · Abdominal Radiology · doi:10.1007/s00261-020-02573-9 · Cited by 90
Moffett, J. R., Arun, P., Puthillathu, N., Vengilote, R., Ives, J. A., Badawy, A. A.-B., & Namboodiri, A. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00031 · Cited by 89
“For example, in Kupffer cells (hepatic macrophages), LPS activates TRL4 receptors, whereas PWM activates the complement system via cleavage of C3 (32).”
BackgroundAcrylamide-Induced Hepatotoxicity Through Oxidative Stress: Mechanisms and Interventions
Zhang, L., Yang, L., Luo, Y., Li, D., & Chen, F. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0055 · Cited by 95
Silva, A. K. S., & Peixoto, C. A. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2838-4 · Cited by 96
Immunotherapy in hepatocellular carcinoma
Buonaguro, L., Mauriello, A., Cavalluzzo, B., Petrizzo, A., & Tagliamonte, M. (2019) · Annals of Hepatology · doi:10.1016/j.aohep.2019.04.003 · Cited by 66
Li, J., Wang, X., Mei, K., Chang, C. H., Jiang, J., Liu, X., Liu, Q., Guiney, L. M., Hersam, M. C., Liao, Y., et al. (2020) · Nano Today · doi:10.1016/j.nantod.2020.101061 · Cited by 88
Nanocarrier-mediated antioxidant delivery for liver diseases
Li, S., Li, H., Xu, X., Saw, P. E., & Zhang, L. (2020) · Theranostics · doi:10.7150/thno.38834 · Cited by 94
Liver Inflammation and Hepatobiliary Cancers
Leone, V., Ali, A., Weber, A., Tschaharganeh, D. F., & Heikenwälder, M. F. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.01.012 · Cited by 99
Grayfer, L., Andino, F. D. J., & Robert, J. (2014) · Journal of Virology · doi:10.1128/jvi.00223-14 · Cited by 87
The Functions of Hepatitis B Virus Encoding Proteins: Viral Persistence and Liver Pathogenesis
Zhao, F., Xie, X., Tan, X., Yu, H., Tian, M., Lv, H., Qin, C., Qi, J., & Zhu, Q. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.691766 · Cited by 87
SECs (Sinusoidal Endothelial Cells), Liver Microenvironment, and Fibrosis
Natarajan, V., Harris, E. N., & Kidambi, S. (2017) · BioMed Research International · doi:10.1155/2017/4097205 · Cited by 98
Tang, T., Sui, Y., Lian, M., Li, Z., & Hua, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081949 · Cited by 88
Park, J., Shao, M., Kim, M. Y., Baik, S. K., Cho, M.-Y., Utsumi, T., Satoh, A., Ouyang, X., Chung, C., & Iwakiri, Y. (2017) · Hepatology · doi:10.1002/hep.29051 · Cited by 86
Understanding the Origin and Diversity of Macrophages to Tailor Their Targeting in Solid Cancers
Kielbassa-Elkadi, K., Vegna, S., Ramirez, C. F. A., & Akkari, L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02215 · Cited by 82
Sepehri, M., Sejersen, T. S., Qvortrup, K., Lerche, C. M., & Serup, J. V. (2017) · Dermatology · doi:10.1159/000468149 · Cited by 82
Yao, L., Wang, Y., Shi, J., Liu, Y., Guo, H., Yang, X., Liu, Y., Ma, J., Li, D., Wang, Z., et al. (2021) · Environmental Science & Technology · doi:10.1021/acs.est.1c01726 · Cited by 81
Saikia, P., Bellos, D., McMullen, M. R., Pollard, K. A., de la Motte, C., & Nagy, L. E. (2017) · Hepatology · doi:10.1002/hep.29144 · Cited by 81
Self-citationLi, Y., Xu, Y., Fleischer, C. C., Huang, J., Lin, R., Yang, L. P. H., & Mao, H. Z. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb01695f · Cited by 82
Epidemiology of Liver Cancer in Africa: Current and Future Trends
Okeke, E. N., Davwar, P., Roberts, L. R., Sartorius, K., Spearman, W., Malu, A. O., & Duguru, M. J. (2019) · Seminars in Liver Disease · doi:10.1055/s-0039-3399566 · Cited by 91
Lindquist, M. E., Zeng, K. X., Altamura, L. A., Daye, S. P., Delp, K. L., Blancett, C. D., Coffin, K. M., Koehler, J. W., Coyne, S. R., Shoemaker, C. J., et al. (2018) · Journal of Virology · doi:10.1128/jvi.01083-18 · Cited by 81
Kong, M., Chen, X., Lv, F., Ren, H., Fan, Z., Qin, H., Yu, L., Shi, X., & Xu, Y. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101302 · Cited by 82
MDSCs in liver cancer: A critical tumor-promoting player and a potential therapeutic target
Ma, C., Zhang, Q., & Greten, T. F. (2021) · Cellular Immunology · doi:10.1016/j.cellimm.2021.104295 · Cited by 81
Experimental liver models: From cell culture techniques to microfluidic organs‐on‐chip
Polidoro, M. A., Ferrari, E., Marzorati, S., Lleò, A., & Rasponi, M. (2021) · Liver International · doi:10.1111/liv.14942 · Cited by 82
Gut microbiota: A new piece in understanding hepatocarcinogenesis
Zhou, A., Tang, L., Zeng, S., Lei, Y., Yang, S., & Tang, B. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.01.002 · Cited by 80
A review on molecular mechanism of alcoholic liver disease
Namachivayam, A., & Gopalakrishnan, A. V. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119328 · Cited by 75
Protective effects of curcumin against ischemia-reperfusion injury in the liver
Bavarsad, K., Riahi, M. M., Saadat, S., Barreto, G. E., Atkin, S. L., & Sahebkar, A. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.12.014 · Cited by 79
The Role of Innate Immune Cells in Nonalcoholic Fatty Liver Disease
Nati, M., Chung, K., & Chavakis, T. (2021) · Journal of Innate Immunity · doi:10.1159/000518407 · Cited by 76
Hepatic Macrophage as a Key Player in Fatty Liver Disease
Xu, L., Liu, W., Bai, F., Xu, Y., Liang, X., Ma, C., & Gao, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.708978 · Cited by 76
Chen, K., Ma, J., Jia, X., Ai, W., Ma, Z., & Pan, Q. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.11.005 · Cited by 75
Li, F., Cao, L., Parikh, S., & Zuo, R. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2020.02.021 · Cited by 72
Li, J., Wang, X., Chang, C. H., Jiang, J., Liu, Q., Liu, X., Liao, Y., Ma, T., Meng, H., & Xia, T. (2021) · Small · doi:10.1002/smll.202102545 · Cited by 73
In Vitro Immune Organs-on-Chip for Drug Development: A Review
Shanti, A., Teo, J. C. M., & Stefanini, C. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10040278 · Cited by 74
Metadata
- Authors
- Dixon, L. J., Barnes, M., Tang, H., Pritchard, M. T., & Nagy, L. E.
- Affiliations
- Case Western Reserve University (US)
- Cleveland Clinic (US)
- Venue
- Comprehensive Physiology
- Publisher
- Wiley
- Published
- 2013-04
- Volume
- 3
- Issue
- 2
- Pages
- 785-797
- ISSN
- 2040-4603 (ISSN-L)
- PMC
- PMC4748178
- OpenAlex
- W1490817952
- Cited by
- 628
- References
- 158
- Citations by year
- 2026: 10 · 2025: 43 · 2024: 84 · 2023: 90 · 2022: 69 · 2021: 82 · 2020: 61 · 2019: 51 · 2018: 47 · 2017: 37 · 2016: 26 · 2015: 19 · 2014: 5 · 2013: 4
- Type
- other
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
- Locations
- Comprehensive physiology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Alcohol Abuse and Alcoholism (R01AA011975, P20AA017837, R37AA011876, R01AA016399)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- Kupffer cells, reticuloendothelial system, liver injury, liver repair, macrophage polarization, macrophage plasticity, alcoholic liver disease, non-alcoholic liver disease, inflammation resolution, wound healing
- MeSH terms
- Animals, Humans, Inflammation, Kupffer Cells, Liver, Liver Diseases, Hepatocytes, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.